in addition to investing in new maternal and neonatal health tools and technologies, we aim to adapt interventions used in referral-level facilities so they can be used in homes, communities, and first-level clinics. Misoprostol’s availability in a pill form that does not require injection or refrigeration makes it particularly promising for use by midwives and other frontline workers in home, community, and first-level clinic settings. oxytocin in Uniject™ is another treatment tool being investigated for postpartum hemorrhage. this single-use, prefilled injection device with a temperature/ time indicator could help overcome some of the barriers associated with the conventional use of oxytocin.
